Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vaborbactam (RPX7009) is a β-lactamase inhibitor that is often used in conjunction with meropenem to study pneumonia and CRE infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 177.00 | |
5 mg | In stock | $ 347.00 | |
25 mg | 8-10 weeks | $ 1,140.00 | |
50 mg | 8-10 weeks | $ 1,490.00 | |
100 mg | 8-10 weeks | $ 1,990.00 |
Description | Vaborbactam (RPX7009) is a β-lactamase inhibitor that is often used in conjunction with meropenem to study pneumonia and CRE infections. |
In vitro | The β-lactamase inhibitor vaborbactam can also form an acyl-enzyme complex with Pseudomonas aeruginosa PBP3. We found that vaborbactam inhibits PBP3 (IC50 of 262 μM), and its binding to PBP3 increases the protein thermal stability by about 2°C[1]. |
In vivo | In a neutropenic mouse thigh infection model, the administration of 100 mg/kg meropenem alone and in combination with various doses of vaborbactam against Klebsiella pneumoniae was evaluated. The results showed that intraperitoneal injection of 300 mg/kg meropenem combined with 50 mg/kg vaborbactam resulted in the greatest reduction in bacterial counts compared to the untreated control group[2]. |
Synonyms | RPX7009 |
Molecular Weight | 297.14 |
Formula | C12H16BNO5S |
CAS No. | 1360457-46-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 2 mg/mL (6.73 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vaborbactam 1360457-46-0 Microbiology/Virology Antibacterial RPX-7009 RPX 7009 RPX7009 inhibitor inhibit